Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-24 @ 7:11 PM
NCT ID:
NCT02661503
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven classical Hodgkin lymphoma
* First diagnosis, no previous treatment, 18 to 60 years of age
* Stage IIB with large mediastinal mass and/or extranodal lesions, stage III or IV
Exclusion Criteria:
* Composite lymphoma or nodular lymphocyte-predominant Hodgkin lymphoma
* Previous malignancy (exceptions: basalioma, carcinoma in situ of the cervix uteri, completely resected melanoma TNMpT1)
* Prior chemotherapy or radiotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT02661503
Study Brief:
Protocol Section:
NCT02661503